Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study to Test the Effectiveness of Controlled-Release OROS® Hydromorphone HCl Compared to Placebo in Patients With Chronic Low Back Pain

This study has been completed.
Information provided by (Responsible Party):
Mallinckrodt Identifier:
First received: October 23, 2007
Last updated: March 20, 2012
Last verified: March 2012